关键词: NSCLC Nivolumab PD-1 antibody SMARCA4 SWI/SNF complex
Mesh : Adult Antineoplastic Agents, Immunological / administration & dosage adverse effects therapeutic use Carcinoma, Non-Small-Cell Lung / diagnosis drug therapy genetics Combined Modality Therapy DNA Helicases / genetics Humans Immunohistochemistry Lung Neoplasms / diagnosis drug therapy genetics Male Mutation Neoplasm Metastasis Neoplasm Staging Nivolumab / administration & dosage adverse effects therapeutic use Nuclear Proteins / genetics Tomography, X-Ray Computed Transcription Factors / genetics Treatment Outcome
来 源:
DOI:10.1111/1759-7714.13070
PDF(Sci-hub)
PDF(Pubmed)